Market Overview
The global compression therapy market reached USD 4,450 million in 2025 and is expected to reach USD 5,890 million by 2033, growing at a CAGR of 5.6% during the forecast period from 2026 to 2033.
The market is witnessing steady growth driven by the increasing prevalence of venous and lymphatic disorders and the rising demand for non-invasive treatment solutions.
Market growth is primarily fueled by the rising incidence of conditions such as deep vein thrombosis (DVT), varicose veins, lymphedema, and chronic venous insufficiency. The growing geriatric population, coupled with sedentary lifestyles, obesity, and increasing surgical procedures, is significantly contributing to the expansion of the market. Additionally, the increasing adoption of compression therapy in post-operative care, sports injury management, and rehabilitation is further accelerating demand.
Compression therapy plays a critical role in improving blood circulation, reducing swelling, and preventing clot formation by applying controlled pressure to affected body parts. These therapies include compression garments such as stockings, bandages, wraps, and advanced pneumatic compression devices widely used in hospitals, clinics, and home care settings. Continuous innovations in material technology, smart compression systems, and wearable solutions with digital monitoring capabilities are transforming the market landscape. With increasing awareness of preventive healthcare and the shift toward home-based treatment, the compression therapy market is emerging as an important segment within the global medical devices and rehabilitation industry.
Market Summary
| Metrics | Details |
| Market CAGR | 5.6% |
| Segments Covered | By Technique, By Product Type, By Application, By End Users, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request free Sample
Market Dynamics
The compression therapy market is primarily driven by the rising prevalence of chronic venous and lymphatic disorders such as deep vein thrombosis (DVT), varicose veins, lymphedema, and chronic venous insufficiency. The increasing incidence of lifestyle-related conditions, including obesity, diabetes, and cardiovascular diseases, has significantly contributed to poor blood circulation issues, thereby boosting demand for compression-based treatments. Additionally, the growing geriatric population, which is more prone to circulatory disorders due to reduced mobility and weakened vascular systems, is further accelerating market growth. The increasing number of surgical procedures, particularly orthopedic and post-operative cases, along with a rise in sports-related injuries, has also strengthened the adoption of compression therapy for rehabilitation and recovery purposes.
On the other hand, the market is influenced by evolving trends such as technological advancements in compression devices, including smart wearable systems, portable pneumatic devices, and improved breathable materials that enhance patient comfort and compliance. Growing awareness regarding non-invasive treatment options and preventive healthcare is encouraging wider adoption across homecare settings. However, factors such as stringent regulatory requirements for medical devices and limited awareness in developing regions may restrain market expansion to some extent. Despite these challenges, increasing healthcare infrastructure development, rising patient awareness, and expanding access to advanced treatment solutions are expected to create significant growth opportunities for the compression therapy market in the coming years.
Recent Developments
February 2026: Tactile Medical announced the acquisition of LymphaTech to expand its lymphedema management portfolio, strengthening its capabilities in advanced compression therapy solutions and digital measurement technologies. January 2026: Globally, increasing adoption of home-based compression therapy devices, including portable pneumatic systems, significantly accelerated market growth, driven by rising demand for convenient and long-term management of chronic venous and lymphatic disorders.
December 2025: Leading companies such as Essity Aktiebolag, Cardinal Health, 3M Company, SIGVARIS, and Stryker Corporation expanded their product portfolios, focusing on smart compression systems, wearable devices, and improved material technologies for enhanced patient comfort and compliance.
November 2025: In Asia Pacific, particularly in India and China, the rising prevalence of diabetes, obesity, and venous diseases significantly increased demand for compression garments and stockings, supported by improving healthcare infrastructure and awareness.
October 2025: Globally, manufacturers accelerated innovation in multi-modal compression devices integrating heat, cold, and digital monitoring features, improving treatment effectiveness for post-surgical care, sports injuries, and rehabilitation.
September 2025: Across North America and Europe, increasing geriatric population, growing number of surgical procedures, and rising awareness of preventive healthcare supported strong adoption of compression therapy products, particularly in hospital and homecare settings.
The market is steadily evolving toward technologically advanced, patient-centric, and homecare-based compression solutions, with growth driven by chronic disease prevalence, aging populations, and continuous innovation in wearable and smart therapy systems.
Market Companies and Competitive Landscape
The compression therapy market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include 3M Company, Arjohuntleigh, Bio Compression Systems, Inc., DJO Global, Inc. (Colfax Corporation), Gottfried Medical, Inc., Medline Industries, Inc., BSN medical, Paul Hartmann AG, Smith & Nephew PLC, Medi GmbH & Co. KG among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the compression therapy market globally. For instance, in February 2022, Koya Medical secured USD 26 million in Series B funding to advance a portfolio of active compression therapies for lymphedema and venous disorder.
Smith & Nephew PLC.
Overview:
Smith & Nephew plc is a medical technology company. The Company is engaged in designing and manufacturing technology. It supports healthcare professionals to return their patients to health and mobility by helping them to perform.
Product Portfolio:
PROFORE and PRO GUIDE: PROFORE and PRO GUIDE are multi-layer compression bandaging systems developed to apply sustained graduated compression for the management of venous leg ulcers and associated conditions.
